AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. H.
Right arrow Articles by Choi, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. H.
Right arrow Articles by Choi, B. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 184:1077-1084
© American Roentgen Ray Society

Value of Contrast-Enhanced Sonography for the Characterization of Focal Hepatic Lesions in Patients with Diffuse Liver Disease: Receiver Operating Characteristic Analysis

Se Hyung Kim1, Jeong Min Lee1, Jae Young Lee1, Joon Koo Han1, Su Kyung An1, Chang Jin Han1, Kyoung Ho Lee1, Seung Sik Hwang2 and Byung Ihn Choi1

1 Department of Radiology and Institute of Radiation Medicine, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea.
2 Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.

OBJECTIVE. Our aim was to assess the diagnostic performance of contrast-enhanced agent detection sonographic imaging to characterize focal hepatic lesions in patients with diffuse liver disease in comparison with baseline sonographic images and to determine whether agent detection imaging can reduce the necessity of further diagnostic workup for lesion characterization.

MATERIALS AND METHODS. Contrast-enhanced sonography using 4 g of Levovist at a concentration of 300 mg/mL was performed on 75 focal hepatic lesions in 75 patients with diffuse liver disease. Interval reviews for both baseline without and with contrast-enhanced sonography were performed independently by two radiologists. They were requested to determine the malignity of focal hepatic lesions using a 5-point confidence level and to record the specific diagnoses and the necessity for further imaging for lesion characterization. Radiologists' performances for lesion differentiation using baseline and contrast-enhanced sonography were evaluated using receiver operating characteristic (ROC) analysis. Interobserver agreement was also analyzed.

RESULTS. When contrast-enhanced sonography was used, ROC analysis revealed a significant improvement for both reviewers (area under the receiver operating characteristic curve [Az] = 0.753 and 0.830 and 0.971 and 0.974 at baseline sonography and contrast-enhanced sonography, respectively; p < 0.002) for differentiating malignant and benign focal liver lesions. Contrast-enhanced sonography also improved specificity from 12% to 91% for reviewer 1 and from 26% to 85% for reviewer 2 compared with baseline sonography. Furthermore, excellent interobserver agreement was achieved for contrast-enhanced sonography (weighted {kappa} = 0.919), whereas only good agreement was achieved for baseline sonography (weighted {kappa} = 0.656). A better result for specific diagnosis was obtained by contrast-enhanced sonography (79% and 75%) than by baseline sonography (37% and 48%, p < 0.05). Contrast-enhanced sonography (72% and 63%) outperformed baseline sonography (35% and 28%, p < 0.05) as a confirmatory imaging technique.

CONCLUSION. Contrast-enhanced agent detection sonography can be used to characterize focal hepatic lesions in patients with diffuse liver disease reliably and with a higher diagnostic confidence than baseline sonography. Furthermore, contrast-enhanced sonography reduced the need for further diagnostic workups for focal hepatic lesion characterization.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
E. Quaia, M. D'Onofrio, P. Cabassa, F. Vecchiato, S. Caffarri, F. Pittiani, K. M. Wittkowski, and M. A. Cova
Diagnostic Value of Hepatocellular Nodule Vascularity After Microbubble Injection for Characterizing Malignancy in Patients with Cirrhosis
Am. J. Roentgenol., December 1, 2007; 189(6): 1474 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. Tarantino
Utility of Sonography in Diagnosing Hepatocellular Carcinoma
Am. J. Roentgenol., May 1, 2007; 188(5): W494 - W494.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. M. Lee
Reply
Am. J. Roentgenol., May 1, 2007; 188(5): W495 - W495.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. H. Kim, J. M. Lee, J. Y. Lee, J. K. Han, and B. I. Choi
Contrast-Enhanced Sonography of Intrapancreatic Accessory Spleen in Six Patients
Am. J. Roentgenol., February 1, 2007; 188(2): 422 - 428.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-X. Xu, G.-J. Liu, M.-D. Lu, X.-Y. Xie, Z.-F. Xu, Y.-L. Zheng, and J.-Y. Liang
Characterization of Small Focal Liver Lesions Using Real-time Contrast-Enhanced Sonography: Diagnostic Performance Analysis in 200 Patients.
J. Ultrasound Med., March 1, 2006; 25(3): 349 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.